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dATF4 regulation of mitochondrial folate-mediated
one-carbon metabolism is neuroprotective
Ivana Celardo1,2, Susann Lehmann1,2, Ana C Costa1,2, Samantha HY Loh*,1 and L Miguel Martins*,1
Neurons rely on mitochondria as their preferred source of energy. Mutations in PINK1 and PARKIN cause neuronal death in
early-onset Parkinson’s disease (PD), thought to be due to mitochondrial dysfunction. In Drosophila pink1 and parkin mutants,
mitochondrial defects lead to the compensatory upregulation of the mitochondrial one-carbon cycle metabolism genes by an
unknown mechanism. Here we uncover that this branch is triggered by the activating transcription factor 4 (ATF4). We show that
ATF4 regulates the expression of one-carbon metabolism genes SHMT2 and NMDMC as a protective response to mitochondrial
toxicity. Suppressing Shmt2 or Nmdmc caused motor impairment and mitochondrial defects in flies. Epistatic analyses showed
that suppressing the upregulation of Shmt2 or Nmdmc deteriorates the phenotype of pink1 or parkin mutants. Conversely, the
genetic enhancement of these one-carbon metabolism genes in pink1 or parkin mutants was neuroprotective. We conclude that
mitochondrial dysfunction caused by mutations in the Pink1/Parkin pathway engages ATF4-dependent activation of one-carbon
metabolism as a protective response. Our findings show a central contribution of ATF4 signalling to PD that may represent a new
therapeutic strategy. A video abstract for this article is available at https://youtu.be/cFJJm2YZKKM.
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Eukaryotic cells respond to diverse stress signals with nuclear
gene expression-designed programmes to repair cellular
damage or induce apoptosis. Integration of several forms of
cellular stress such as amino-acid limitation, endoplasmic
reticulum (ER) stress, introduction of double-stranded RNAs
into cells by viral infection and heme limitation are transduced
via eIF2α kinases. Phospho-eIF2α suppresses general protein
synthesis, but promotes a paradoxical increase in translation
of selected mRNA species such as the activating transcription
factor 4 (ATF4) (reviewed in Kilberg et al.1). Mammalian ATF4,
in turn, activates downstream transcriptional programmes
designed to induce a cellular adaptation to stress. ATF4
signalling regulates a wide array of genes involved in the
response to amino-acid imbalance2,3 as well as redox
enzymes.
Some autosomal recessive forms of Parkinson’s (PD)
disease are caused by mutations in PINK1 or PARKIN, two
genes involved in mitochondrial quality control (reviewed in
Celardo et al.4). In Drosophila melanogaster, mutations in
either pink1 or parkin cause mitochondrial dysfunction linked
to the accumulation of defective organelles. Studies in this fly
model showed that mitochondrial stress in pink1 mutant
results in the transcriptional activation of mitochondrial folate-
mediated one-carbon metabolism genes as a protective
response through an unknown mechanism.5 Folate one-
carbon metabolism shuttles one-carbon units for biosynthetic
pathways, including nucleotide biosynthesis and methylation
reactions. Enhancing one-carbon metabolism by exogenous
administration of folic acid rescued mitochondrial defects in
both flies and cultured human cells.5 The mitochondrial one-
carbon metabolism was remodelled following mitochondrial
dysfunction caused by defects in the replication of mitochon-
drial DNA (mtDNA) in mice.6
One-carbonmetabolism (reviewed in Tibbetts and Appling7)
comprises two parallel pathways: one in the cytosol and one in
mitochondria. Mitochondrial serine hydroxymethyl transferase
(SHMT2) converts serine into glycine and a formyl unit
attached to tetrahydrofolate (THF) that is further converted
to 10-formyl-THF by NAD-dependent methylenetetrahydrofo-
late dehydrogenase (NMDMC), also known as mitochondrial
methylenetetrahydrofolate dehydrogenase (MTHFD2).
10-formyl-THF is required to make formylmethionine for
mitochondrial protein synthesis.8 These mitochondrial one-
carbon metabolism enzymes are essential for both embryonic
development9 and tumourigenesis,10 and both SHMT2 and
NMDMC are consistently upregulated in rapidly proliferating
cancer cells.11–13
We found that ATF4 controls the expression of the
mitochondrial one-carbon metabolism genes SHMT2 and
NMDMC as a protective response to mitochondrial toxicity. In
vivo RNAi-mediated downregulation of Shmt2 or Nmdmc
caused mitochondrial impairment. Conversely, their genetic
enhancement suppressed neurodegeneration in both pink1
and parkin mutant flies.
We conclude that mitochondrial dysfunction following
disruption of the Pink1/Parkin pathway can be suppressed
by the genetic enhancement of mitochondrial
one-carbon metabolism. This shows that the one-carbon
metabolism pathway is not only critical for the survival of
proliferating cells such as cancer cells but also sustains
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the viability of post-mitotic cells such as neurons by promoting
mitochondrial health.
Results
Identification of ATF4 as an upstream regulator of one-
carbon metabolism genes in pink1 and parkin mutants.
We have previously observed an upregulation of nucleotide
metabolism pathways, including the one-carbon metabolism
enzymes, in the heads of Drosophila pink1 (pink1B9) mutants
flies.5 As Parkin cooperates with Pink1 in a pathway involved
in mitochondrial quality control (QC), we compared the
expression of genes involved in the mitochondrial one-
carbon metabolism between pink1 and parkin (park25)
mutants. This revealed a significant increase in mitochondrial
transcripts for one-carbon enzymes in the heads of both
pink1 and parkin mutants (Figure 1a), indicating that these
transcripts are upregulated upon dysfunction of the Pink1/
Parkin mitochondrial QC pathway.
To determine how mitochondrial stress in pink1 and parkin
mutants modulates the expression of genes involved in
nucleotide metabolism, we explored the mechanism
underlying transcriptional changes upon mitochondrial dys-
function. To identify the upstream regulators of altered nuclear
gene expression in pink1 or parkin mutants, we employed
microarray technology coupled with an in silico approach
(experimental outline, Figure 1b). We used Ingenuity
upstream regulator analysis, a causal analytics algorithm
designed to identify upstream regulators that are connected to
data set genes.14 This analysis, applied to the full complement
of transcriptional changes in either pink1 or parkin mutant
heads, revealed a subnetwork of transcriptional changes
linked to the upstream triggering of ATF4 as well as to the
inhibition of the tribbles pseudokinase 3 (TRB3), a negative
feedback regulator of ATF4-dependent transcription,15 in both
pink1 and parkinmutants (Figure 1c and Supplementary Table
1). We have previously shown that mutations in pink1 or parkin
result in a translational shutdown16 that normally coincides
with an increase in ATF4 activity.17,18 As ATF4 activation is
linked to amino-acid imbalances, we next measured the
endogenous amino-acid levels in pink1 and parkin mutant
flies. This metabolic analysis revealed an amino-acid imbal-
ance in both pink1 and parkinmutants, resulting in an increase
in the majority of free amino acids (Po0.001, χ2, Figure 1d).
e
Figure 1 In silico identification of ATF4 as a regulator of transcriptional changes in pink1 and parkin mutants. (a) Enhanced expression of one-carbon metabolism genes
Shmt2, Nmdmc, CG3999 (GCS P protein, glycine dehydrogenase) and CG6415 (GCS T protein, aminomethyl transferase) in heads of 3-day-old pink1 or parkin mutant flies.
Relative levels to the w1118 control flies are indicated. Red corresponds to transcripts that are upregulated to a significant (P⩽ 0.05) level. Significance was determined using a
two-tailed unpaired t-test (3 to 8 biological replicates per sample). (b) Workflow employed for the identification of upstream regulators of transcriptional changes upon loss of pink1
or parkin. (c) Analysis of upstream modulators of gene expression changes observed in pink1 (pink1B9) and parkin (park25) mutant flies. The term ‘young’ corresponds to heads
from 3-day-old pink1 and parkin mutant flies and ‘aged’ to heads from 21- and 30-day-old parkin and pink1 mutant flies, respectively. The activation z-scores for ATF4 and TRIB3
are indicated. Red and blue correspond to significant positive (z ⩾ 2) and negative (z ⩽ − 2) scores, respectively. Target molecules labelled in red correspond to positive
transcripts regulated in the analysed data sets. (d) Changes in amino-acid abundance upon the loss of pink1 or parkin function. Relative levels to the w1118 control flies are
indicated. Red and blue correspond to metabolites that are upregulated and downregulated to a significant level, respectively. ND corresponds to an amino-acid below detection
threshold. Significance was determined using Welch’s two-sample t-test (n= 8). (e) Analysis of dAtf4 protein levels. Whole-fly lysates were analysed by western blotting using the
indicated antibodies. The first two lanes correspond to a control for the specificity of the anti-dAtf4 antibody performed by analysing the levels of overexpressed dAtf4 in transgenic
flies (da4 UAS dAtf4). Genotypes: da4+, daGal44 +; da4 UASdAtf4, daGal44 UASdAtf4; control, w1118
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We next assessed the protein levels of dAtf4 in pink1 and
parkin mutant flies. This revealed an increase in dAtf4 in both
pink1 and parkin adult animals (Figure 1e).
ATF4 is required for the upregulation of SHMT2 and
NMDMC upon stress induction. ATF4 mediates the induc-
tion of protective genes such as those involved in amino-acid
metabolism and oxidative stress.3 An analysis of the human
orthologues of the mitochondrial one-carbon metabolism
genes upregulated in pink1 and parkin mutants using the
‘Grow tool’ in Ingenuity Pathway Analysis (IPA) suggested
that ATF4 is a direct modulator of the SHMT2 and NMDMC
transcripts (Figure 2a). To determine the role of dATF4 in the
regulation of Drosophila Shmt2 and Nmdmc, we down-
regulated its expression using RNA interference (RNAi).
dATF4 RNAi resulted in a decrease in the basal transcript
levels of Shmt2 and Nmdmc (Figure 2b), indicating that
dATF4 suppression is sufficient to downregulate their
expression.
We next tested whether ATF4 also acts as an upstream
regulator of SHMT2 and NMDMC in mammalian cells. ATF4
can induce transcriptional changes after toxic insults pro-
moted by classical ER stressors or oxidative stress.19 We
treated cultured mammalian cells with thapsigargin, a sarco/
endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor, or
rotenone, a mitochondrial complex I inhibitor. These treat-
ments led to the accumulation of ATF4 (Figures 2c and d) and
promoted the transcriptional upregulation of both SHMT2 and
NMDMC, as well as a more pronounced upregulation of
CHOP (DDIT3), a classical ATF4 target gene, in SH-SY5Y
neuroblastoma cells (Figures 2e and f). Following RNAi-
mediated downregulation of ATF4 (Figure 2g), the upregula-
tion of both SHMT2 and NMDMC in cells treated with ATF4-
activating toxinswas blocked (Figures 2h and i), indicating that
ATF4 lies upstream of the activation of both of these
one-carbon metabolism transcripts upon ER or mitochondrial
stress.
Suppression of Drosophila Shmt2 or Nmdmc affects
development and causes mitochondrial dysfunction. To
investigate the in vivo role of Shmt2 and Nmdmc, we
determined the consequences of their suppression using
RNAi (Figure 3a). The knockdown of Shmt2 or Nmdmc
caused developmental defects characterized by a significant
failure of eclosion (Figure 3b). Analysis of the eclosed adults
revealed that the knockdown of Shmt2 or Nmdmc resulted in
an impaired climbing ability, suggesting a locomotor deficit
(Figure 3c), and decreased lifespan (Figure 3d). The knock-
down of either Shmt2 or Nmdmc led to significant metabolic
changes in several canonical pathways, most significantly
those related to nucleotide degradation and salvage
(Figure 3e and Supplementary Table 2). To further determine
whether the consequences of Shmt2 or Nmdmc knockdown
were linked to mitochondrial defects, we performed a
morphological and functional analysis of mitochondria. This
revealed a fragmented mitochondrial network (Figures 4a
and b) that was associated with a loss of mitochondrial
membrane potential (Δψm) in adult brain (Figures 4c and d)
as well as a generalized loss of mitochondrial proteins
(Figure 4e). In addition, Nmdmc knockdown adult flies
exhibited an abnormal downturned wing posture (Figure 4f)
and ultrastructural analysis of their indirect flight muscles
revealed mitochondria with fragmented cristae (Figure 4g).
Taken together, these data suggest that the loss of the
mitochondrial one-carbon metabolism genes Shmt2 and
Nmdmc results in mitochondrial dysfunction.
Suppressing the upregulation of Shmt2 or Nmdmc
deteriorates the PD-linked phenotypes in pink1 and
parkin mutants. To confirm that transcripts for the one-
carbon metabolism genes Shmt2 and Nmdmc are induced in
pink1 and parkin mutants as a compensatory mechanism for
mitochondrial dysfunction, we tested the consequences of
their suppression in these mutants. As ATF4 is required for
the upregulation of SHMT2 and NMDMC in mammalian cells,
we first determined the in vivo consequences of suppressing
its expression in pink1 or parkin mutant flies. The knockdown
of dAtf4 led to 11% and 84% lethality, respectively, in pink1
and parkin mutants (Figure 5a). Analysis of the surviving
pink1 and parkin mutant adults with dAtf4 knockdown
confirmed the downregulation of the dAtf4 transcript
(Figure 5b) and revealed an increased penetrance of the
crushed-thorax phenotype (Figures 5c and d). In addition,
dAtf4 knockdown caused a decline in the climbing perfor-
mance of pink1 mutants (Figure 5e). We next assessed the
effect of dAtf4 knockdown on the levels of Shmt2 and Nmdmc
in pink1 and parkin mutants. This caused a moderate
decrease in Shmt2 and a more pronounced decrease in
Nmdmc transcript levels (Figures 5f and g). Taken together,
these results show that dAtf4 is involved in the upregulation of
Shmt2 and Nmdmc in pink1 and parkin mutants. Next, we
tested the effects of downregulating Shmt2 or Nmdmc in
pink1 or parkin mutants. The knockdown of Shmt2 or Nmdmc
led to 100% and 99% lethality, respectively, in parkin mutants
(Figure 5h). In pink1 mutants, the knockdown of Shmt2 or
Nmdmc reduced their respective transcript levels (Figure 5i),
and caused 84 and 19% lethality, respectively (Figure 5j).
Analysis of the surviving adults revealed an increased
penetrance of the crushed-thorax phenotype in both Shmt2
and Nmdmc knockdown (Figure 5k). Furthermore, Nmdmc
knockdown exhibited a dramatic decline in the climbing
performance of pink1 mutants (Figure 5l). These results
suggest that the one-carbon metabolism genes, Shmt2 and
Nmdmc, were upregulated as a protective mechanism in
pink1 and parkin mutants.
Expression of Shmt2 or Nmdmc rescues the PD-linked
phenotypes in pink1 and parkin mutants. We previously
showed that the pharmacological enhancement of folic acid
metabolism confers a protective effect on the mitochondria of
pink1 or parkin mutants.5 We therefore examined the effects
of overexpressing one-carbon metabolism genes, Shmt2 and
Nmdmc, in pink1 or parkin mutants. We first confirmed the
overexpression of either Shmt2 or Nmdmc (Figures 6a and b)
in adult flies. Next, by targeting the expression of these
genes, using a neuronal driver, we rescued the mitochondrial
function in neurons (Figure 6c) and the loss of dopaminergic
neurons in the PPL1 cluster of both pink1 and parkin mutants
(Figures 6d–f). Taken together, these results show that the
one-carbon metabolism genes have a neuroprotective role in
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the Pink1/Parkin PD model. We showed that Shmt2 and
Nmdmc expression is in part mediated by ATF4 in pink1 and
parkin mutants (Figures 5f and g). ATF4 can be activated by
the ER stress-inducible kinase PERK and Gcn2, a kinase
that acts as a sensor of amino-acid depletion by binding
uncharged tRNAs and phosphorylating eIF2α on serine 51
siR
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Figure 2 ATF4 regulates the expression of Shmt2 and Nmdmc. (a) In silico identification of SHMT2 and NMDMC (red) as direct downstream transcriptional targets of ATF4.
ATF4 could be directly connected to SHMT2 and NMDMC using the ‘Grow tool’ in IPA. The other one-carbon metabolism genes, CG3999 (GCS P protein, glycine dehydrogenase)
and CG6415 (GCS T protein, aminomethyl transferase) (green), found to be upregulated in the heads of pink1 or parkin mutant flies are also shown. A schematic diagram of
metabolites related to these enzymes is also shown. (b) dATF4 RNAi flies show a downregulation of mitochondrial Shmt2 and Nmdmc (mean± S.D.; asterisks, one-way ANOVA
with Bonferroni’s multiple comparison test). Genotypes: Control: elavGAL4, all RNAi were driven by elavGAL4. (c and d) Increased levels of ATF4 following toxin-induced ER or
mitochondrial stress. SH-SY5Y cells were incubated for 8 h in the presence of the indicated concentrations of the ER stressor thapsigargin (c) or the complex I inhibitor rotenone
(d). Cell lysates were analysed using the indicated antibodies. (e and f) Transcriptional upregulation of SHMT2, NMDMC and CHOP following ER or mitochondrial stress
(mean± S.D.; asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). SH-SY5Y cells were incubated for 8 h in the presence of the indicated concentrations of
thapsigargin (Tg) (e) or rotenone (Rot) (f). (g) Downregulation of ATF4 in SH-SY5Y cells. The fold change of the indicated transcript levels compared with control siRNA is
indicated (mean± S.D.; asterisks, one-tailed unpaired t-test relative to control). (h and i) The siRNA-mediated downregulation of ATF4 blocks the toxin-induced transcriptional
upregulation of SHMT2 and NMDMC. Analysis of SHMT2 and NMDMC transcript levels in ATF4 RNAi cells following toxin treatment. SH-SY5Y cells were incubated for 8 h in the
presence of the indicated concentrations of thapsigargin (Tg) (h) or rotenone (Rot) (i) (mean±S.D., n= 3; asterisks, one-way ANOVA for the siRNA variable with Bonferroni’s
multiple comparison test, P-value for the siRNA-drug interaction two-way ANOVA is also indicated)
Mitochondrial 1C metabolism is neuroprotective
I Celardo et al
641
Cell Death and Differentiation
(reviewed in Kilberg et al.1). We showed that suppression of
protein kinase R-like endoplasmic reticulum kinase (PERK)
is neuroprotective in pink1 and parkin mutants.16 As we
observed significant alterations in amino-acid levels in pink1
and parkin mutants (Figure 1d), we tested whether Droso-
phila Gcn2 (dGcn2) also plays a role in the activation of ATF4
in these mutants. RNAi-mediated suppression of dGcn2
failed to rescue the neuronal loss in pink1 or parkin mutant
Figure 3 In vivo suppression of Shmt2 or Nmdmc affects development and causes motor impairment in adult flies. (a) RNAi-mediated suppression of Shmt2 or Nmdmc.
Expression levels were measured by real-time qPCR (mean±S.D.). The significant values relative to the control are indicated (asterisks, two-tailed unpaired t-test compared with
Control). (b) Eclosion defects following RNAi-mediated suppression of Shmt2 or Nmdmc (asterisks, χ2 two-tailed, 95% confidence intervals). (c) Motor impairment upon RNAi-
mediated suppression of Shmt2 or Nmdmc. Flies were tested using a standard climbing assay (mean± S.D.; asterisks, one-way ANOVAwith Dunnett’s multiple comparison test).
(d) Decreased lifespan upon RNAi-mediated suppression of Shmt2 or Nmdmc. Fly viability was scored over a period of 90 days (n= 165 for Control (left panel), n= 68 for Shmt2
RNAi#1, n= 108 for Shmt2 RNAi#2, n= 143 for Control (right panel), n= 116 for Nmdmc RNAi#1, n= 102 for Nmdmc RNAi#2; asterisks, log-rank, Mantel-Cox test).
(e) Coordinated changes in metabolite abundance on the downregulation of Shmt2 or Nmdmc. Canonical pathways altered in both Shmt2 and Nmdmc RNAi flies were analysed
using the IPA Comparison Analysis tool. The heat map corresponds to the –log (P-value) for the canonical pathways significantly perturbed by the downregulation of either Shmt2
or Nmdmc (cutoff for P-value is 0.001 for both Shmt2 and Nmdmc RNAi data sets). Genotypes in (a–e): Control: daGAL4. All RNAi lines were driven by daGAL4
Figure 4 Suppression of Shmt2 or Nmdmc causes mitochondrial defects. (a and b) RNAi-mediated suppression of Shmt2 or Nmdmc results in mitochondrial fragmentation.
(a) Confocal analysis of mitoGFP in the indicated larval tissues. (b) The quantification of mitochondrial length from larval nerve is indicated (mean± S.D., P-value, one-way
ANOVA with Bonferroni’s multiple comparison test). (c) Representative confocal image of a whole mounted control brain showing neurons loaded with TMRM. (d) Loss of Δψm
following RNAi-mediated suppression of Shmt2 or Nmdmc. The data are shown as the mean±S.D. (asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). (e)
Loss of mitochondrial proteins in Shmt2 and Nmdmc RNAi flies. Whole-fly lysates from 3-day-old flies were analysed by western blot analysis using the indicated antibodies. (f)
Abnormal wing posture following RNAi-mediated suppression of Nmdmc (asterisks, χ2 two-tailed, 95% confidence intervals). (g) The knockdown of Nmdmc causes mitochondrial
cristae fragmentation. Ultrastructural analysis of the indirect flight muscles in Nmdmc RNAi flies (my, myofibrils; m, mitochondria; yellow outlines, mitochondria). Percentages of
indirect-flight-muscle mitochondria exhibiting fragmented cristae normalized to area are presented (asterisks, χ2 two-tailed, 95% confidence intervals). Genotype in (a and b):
Control: elavGAL44mitoGFP; Shmt2 RNAi #1: elavGAL44mitoGFP, Shmt2 RNAi #1; Nmdmc RNAi #1: elavGAL44mitoGFP, Nmdmc RNAi #1, (c and d): Control: elavGAL4.
All RNAi lines were driven by elavGAL4, (e–g): Control: daGAL4. All RNAi lines were driven by daGAL4
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flies (Figure 6g). Together, these results indicate that in pink1
and parkin mutants, ATF4 is regulated via PERK.
Discussion
The mitochondrial retrograde response acts as a sensitive
feedback system to fine-tune mitochondrial performance. We
have shown that genes affecting key nucleotide metabolic
processes alleviate stress through metabolic readjustments
that stimulate mitochondrial function and block
neurodegeneration.5 Furthermore, we reported that mitochon-
drial dysfunction in pink1 or parkin mutants activates ER
stress signalling.16 Here, we used an exploratory approach to
determine the mechanism underlying the regulation of gene
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expression following mitochondrial dysfunction in the Pink1/
Parkin pathway. Using a web-based analytical tool, we found
evidence for the involvement of ATF4 in the activation of the
mitochondrial one-carbon metabolism genes Shmt2 and
Nmdmc in pink1 and parkin mutant flies.
We provide evidence that the one-carbon metabolism
genes Shmt2 and Nmdmc are under the control of ATF4.
Both the ER toxin thapsigargin and the mitochondrial poison
rotenone led to the ATF4-dependent activation of SHMT2 and
NMDMC, most likely to alleviate stress.
Several cellular stress signals transduced through four
eIF2α kinases led to global translation shutdown but also
promoted a paradoxical increase in the translation of specific
mRNAs, such as that for ATF4 (reviewed in Kilberg et al.1). We
have reported that mitochondrial stress in pink1 or parkin
mutant flies results in global translational shutdown via PERK,
an eIF2α kinase, with neurotoxic consequences.16 In spite of
the global translational shutdown, transcripts for Shtm2 and
Nmdmc are upregulated in pink1 and parkin mutants
(Figures 5f and g and Tufi et al.5), and here we report that
their overexpression via ATF4 is neuroprotective. This
illustrates another paradox linked to the activation of PERK.
How can PERK signalling cause translational shutdown with a
neurotoxic outcome whereas via ATF4 it promotes the
activation of neuroprotective genes? We propose that this
could result from a compromised biphasic response to PERK
activation in neurons. The short-term PERK-dependent
translational shutdown in cells is followed by a recovery of
translation via GADD34-dependent dephosphorylation of
eIF2α (reviewed in Kilberg et al.1). However, the sustained
phosphorylation of eIF2α in neurons of pink1 or parkinmutants
might not be able to sustain an efficient translation of ATF4
targets even though their mRNA pools are increased.
Eukaryotic one-carbon metabolism comprises parallel
cytosolic and mitochondrial pathways connected by the one-
carbon donors serine, glycine and formate. We show here that
compromising the mitochondrial one-carbon pathway by
downregulating Shmt2 orNmdmc leads to significant changes
in nucleotide pathways.Shmt2 orNmdmc silencing resulted in
mitochondrial dysfunction and led to both developmental
defects and decreased viability of adult flies. This result
suggests that mitochondrial one-carbon metabolism is impor-
tant for the normal function of these organelles. pink1 or parkin
mutants show a significant upregulation of transcripts for
Shmt2 and Nmdmc (Figures 5f, g and i). We propose that the
enhanced Shmt2 and Nmdmc transcripts levels represents a
compensatory attempt to revert the mitochondrial dysfunction
caused by defects in the Pink1/Parkin pathway, as the rescue
of neurodegeneration in either pink1 or parkinmutants can be
achieved by the overexpression of either Shmt2 or Nmdmc. If
both Shmt2 and Nmdmc are already upregulated in pink1 or
parkin mutants, why then do we need to artificially enhance
their expression to achieve neuroprotection in these flies? It is
conceivable that even if their transcription is increased, their
protein levels remain at basal levels because of the sustained
inhibition of translation present in pink1 or parkin mutants.16
Currently, this cannot be confirmed as we do not have
reagents capable of detecting endogenous levels of Shmt2
or Nmdmc in flies.
We conclude that mitochondrial dysfunction caused by the
loss of pink1 and parkin in flies engages dATF4-dependent
protectivemechanisms. Post-mitotic cells such as neurons are
reported to lack the de novo nucleotide biosynthetic pathways
and rely instead on the salvage pathway;20 however, both
Shmt2 and Nmdmc are components of one-carbon metabo-
lism involved in the de novo biosynthetic pathway. Therefore,
our observation that the overexpression of either of these
genes can suppress neurodegeneration in fly models of PDs
challenges the notion that de novo nucleotide biosynthetic
pathways are irrelevant in postmitotic cells such as neurons.
In conclusion, we propose mitochondrial one-carbon
metabolism is critical in at least two separate settings: it not
only ensures the accurate nuclear DNA replication in
proliferating cells such as cancer or embryonic cells but also
counteracts mitochondrial dysfunction in post-mitotic cells
such as neurons.
Materials and Methods
Genetics and Drosophila strains. Fly stocks and crosses were
maintained on standard cornmeal agar media at 25 °C. The strains used were
pink1B9, park25 and daGAL4 (kind gifts from A Whitworth, MRC, Centre for
Developmental and Biomedical Genetics, University of Sheffield, Sheffield, UK),
w1118, elavGAL4 (Bloomington Stock Centre, Bloomington, IN, USA) and RNAi
lines: Shmt2 (RNAi#1, ID: 19206; RNAi#2, ID: 19208), Nmdmc (RNAi#1, ID: 5706;
RNAi#2, ID: 110198), dAtf4 (RNAi#1, ID: 2935; RNAi#2, ID: 109014) and dGcn2
(ID: 103976) (Vienna Drosophila RNAi Centre, Vienna, Austria). UAS dAtf4 was
from Zurich ORFeome Project (Zurich, Switzerland) (ID: F000106). HA-tagged
cDNA fragments encoding full-length Shmt2 (ID: RH67089) and Nmdmc (ID:
GH01066) from Drosophila Genomics Resource Center (Bloomington, IN, USA)
were cloned into pUASTattB vector for PhiC31-mediated site-directed transgenesis.
Transgenic flies were generated at the Cambridge fly facility, Department of
Genetics, University of Cambridge (Cambridge, UK). All the experiments on adult
flies were performed with males.
Metabolic profiling. Global metabolic profiles were obtained from 3-day-old
flies using the Metabolon Platform (Metabolon Inc., Morrisville, NC, USA) as
previously described.5 Essentially, each sample consisted of 8 biological replicates
(100 flies per replicate). The sample preparation process was carried out using the
automated MicroLab STAR system from Hamilton Company (Bonaduz, GR,
Switzerland). For sample extraction, 80% (v/v) methanol/water solution was used.
Samples were then prepared for the appropriate instrument, either LC/MS or GC/
MS. Compounds above the detection threshold were identified by comparison with
library entries of purified standards or recurrent unknown entities. Identification of
known chemical entities was based on comparison with metabolomic library entries
of purified standards.
Microarray acquisition and analysis. RNA was prepared from the heads
of male adult flies (6 samples in total, 3 replicates for each genotype). The RNA
quality was confirmed using an Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA). Detailed experimental protocols and raw data were
deposited in ArrayExpress under accession E-MTAB-1406. Differential expression
was analysed using the Partek Genomics Suite (Partek Inc., St. Louis, Missouri,
USA).
Pathway analysis. Data were processed using the Ingenuity Pathway Analysis
(IPA), build 313398M, content version 18841524 (QIAGEN, Hilden, Germany). To
determine the putative modulators of the observed expression changes in pink1B9
and park25 mutant flies, we employed the IPA Comparison Analysis using the
Upstream Regulator analytic sub-routine. This programme computes two statistical
measures for each potential transcriptional regulator (TR): an overlap P-value and
an activation z-score. The overlap P-value calls likely upstream regulators based on
significant overlap between data set genes and known targets regulated by a TR.
The activation z-score is used to infer likely activation states of upstream regulators
based on comparison with a model that assigns random regulation directions.14 In
practice, z-scores greater than 2 or smaller than − 2 can be considered significant.
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Figure 5 Suppressing the upregulation of Shmt2 or Nmdmc deteriorates the phenotype of pink1 or parkin mutants. (a) RNAi-mediated suppression of dAtf4 enhances
lethality in parkin and pink1 mutants (asterisks, χ2 two-tailed, 95% confidence intervals). (b) RNAi-mediated suppression of dAtf4 in pink1 or parkin mutants. Expression levels
were measured by real-time qPCR (mean± S.D.). The significance is indicated (asterisks, two-tailed unpaired t-test). (c) Representative images of normal and defective thorax in
pink1 mutant, arrow points to a thoracic defect. (d) Enhancement of the thoracic defects in pink1 or parkin mutants by RNAi-mediated suppression of dAtf4 (asterisks, χ2 two-
tailed, 95% confidence intervals). (e) Enhancement of the motor impairment of pink1mutants by RNAi-mediated suppression of dAtf4. Flies were tested using a standard climbing
assay (mean±S.D.; asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). (f and g) RNAi-mediated suppression of dAtf4 in pink1 or parkin mutants affects the
transcript levels of Shmt2 (f) andNmdmc (g). Expression levels were measured by real-time qPCR (mean± S.D.). The significance is indicated (P-value, two-tailed unpaired t-test
compared with pink1B9 or park25). (h) RNAi-mediated suppression of Shmt2 or Nmdmc enhances lethality in parkin mutants (asterisks, χ2 two-tailed, 95% confidence intervals).
(i) RNAi-mediated suppression of Shmt2 or Nmdmc in pink1 mutants. Expression levels were measured by real-time qPCR (mean±S.D.). The significant values relative to the
control are indicated (asterisks, two-tailed unpaired t-test compared with Control). (j) RNAi-mediated suppression of Shmt2 or Nmdmc enhances lethality in pink1 mutants
(asterisks, χ2 two-tailed, 95% confidence intervals). (k) Enhancement of the thoracic defects of pink1 mutants by RNAi-mediated suppression of Shmt2 or Nmdmc (asterisks, χ2
two-tailed, 95% confidence intervals). (l) Enhancement of the motor impairment of pink1 mutants by RNAi-mediated suppression of Nmdmc. Flies were tested using a standard
climbing assay (mean±S.D.; asterisks, one-way ANOVA with Bonferroni’s multiple comparison test). Genotypes in (a and b and d–l): Control: daGAL4; park25: park25, daGAL4/
park25; pink1B9: pink1B9, daGAL4. All RNAi lines were driven by daGAL4. (c): Control: w1118
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For the identification of coordinate changes in metabolite abundance in Shmt2 and
Nmdmc RNAi strains, we employed the IPA Comparison Analysis workflow. This
programme computes a P-value (Fisher’s exact test) based on significant overlap
between the observed metabolic changes and known canonical pathways defined
by the HumanCyc metabolic pathway information data set (QIAGEN).
Cell culture and transfections. SH-SY5Y were cultured in DMEM/F12 1:1
(Gibco BRL, Waltham, MA, USA) supplemented with 10% heat-inactivated FCS
(Invitrogen, Waltham, MA, USA), 100 U/ml penicillin (Gibco BRL) and 100 μg/ml
streptomycin (Gibco BRL). The cells were maintained at 37 °C in 5% CO2 in culture
medium. RNA silencing was performed by delivering siRNA at a concentration of
10 nM into SH-SY5Y cells. Lipofectamine RNAiMAX (Invitrogen) was used as the
transfection reagent. The siRNA was obtained from Dharmacon (Lafayette, CO,
USA) (ON-TARGETplus Non-targeting Pool, #D-001810-10-05; ATF4, SMARTpool:
ON-TARGETplus L-005125-00-0005).
Protein extraction and western blotting. Protein extracts from whole
flies were prepared by grinding flies in lysis buffer (100 mM KCl, 20 mM Hepes at
pH 7.5, 5% (v/v) glycerol, 10 mM EDTA, 0.1% (v/v) Triton X-100, 10 mM DTT,
1 μg/ml leupeptin, 1 μg/ml antipain, 1 μg/ml chymostatin and 1 μg/ml pepstatin).
Protein extracts from cells were prepared by scraping them in lysis buffer (20 mM
Tris at pH 7.5, 150 mM NaCl, 1% (v/v) Nonidet-40, 0.5% (w/v) sodium deoxycholate,
0.1% (w/v) SDS) containing phosphatase inhibitor cocktail tablets PhosSTOP
(Roche, Basel, Switzerland) and the protease inhibitors leupeptin, antipain,
chymostatin and pepstatin (Sigma, Dorset, UK) at the manufacturer’s recommended
dilution. The suspensions were cleared by centrifugation at 21 000 × g for 10 min at
4 °C and protein concentrations of the supernatants were measured using the
Bradford assay (Bio-Rad, Hercules, CA, USA). For the dATF4 immunoblot, protein
extracts from whole flies were prepared by grinding flies in the same buffer as those
for protein extraction from cells. All supernatants were mixed with 4 × LDS loading
buffer. For SDS-PAGE, equivalent amounts of proteins were resolved on 4–12% or
10% Precast Gels (Invitrogen) and transferred onto PVDF membranes (Millipore,
Watford, UK). The membranes were blocked in TBS (0.15 M NaCl and 10 mM Tris-
HCl, pH 7.5) containing 10% (w/v) dried non-fat milk for 1 h at room temperature,
probed with the indicated primary antibody before being incubated with the
appropriate HRP-conjugated secondary antibody. Antibody complexes were
visualized by Pierce (Waltham, MA, USA) enhanced chemiluminescence (ECL).
Antibodies. Primary antibodies employed in this study were α-tubulin (Sigma,
T6074), HA (Roche Applied, Basel, Switzerland, 11583816001), ATF4 to probe
human cell samples (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-22800),
dATF4 to probe Drosophila samples (a kind gift from Min Kang, University of Ulsan,
Seoul, South Korea), GAPDH (Sigma, G8795), NDUFS3/complex I (Abcam,
Cambridge, UK, ab14711), mtCO1 (Abcam, ab90668), α-tubulin (Sigma, T6074)
and TH (Immunostar, Hudson, WI, USA, 22941).
RNA extraction and quantitative real-time RT-PCR. Total RNA was
extracted using the RNeasy Mini Kit (QIAGEN; for mammalian cells) or TRIzol
(Ambion, Waltham, MA, USA; for Drosophila tissues) and quantified by spectro-
photometric analysis. Quantitative real-time PCR with reverse transcription (qRT–
PCR) was performed on a real-time cycler (Applied Biosystems, Foster City, CA,
USA, 7500 Fast Real-Time PCR Systems) using the SensiFAST SYBR Lo-ROX
one-Step Kit (Bioline, London, UK). Gene-specific primers were obtained from
QIAGEN (QuantiTect Primer Assays) for the following genes: DDIT3 (QT00082278),
dATF4 (QT00503069), CG3999 (QT00972349), CG6415 (QT00934318), Nmdmc
(dm: QT00503153, hs: QT00081592), Parkin (QT00023401), Pink1 (QT01670459)
and Shmt2 (dm: QT00498904, hs: QT00012754). Gene-specific primers obtained
from Sigma were: hsATF4 (forward, 5′-CCCTTCACCTTCTTACAACCTC-3′;
reverse, 5′-GTCTGGCTTCCTATCTCCTTCA-3′), rp49 (forward, 5′-TGTCCTTC
CAGCTTCAAGATGACCATC-3′; reverse, 5′-CTTGGGCTTGCGCCATTTGTG-3′),
TBP (forward, 5′-TCAAACCCAGAATTGTTCTCCTTAT-3′; reverse, 5′-CCTGAATC
CCTTTAGAATAGGGTAGA-3′). rp49 and TBP were used as housekeeping genes
when analysing fly and cells samples, respectively.
Immunofluorescence and confocal microscopy. To analyse the
mitochondria in larvae brains and ventral nerve cord nerves, tissues from third-instar
larvae were dissected in PBS, transferred to a drop of PBS as mounting medium on glass
slides, covered with coverslip and imaged on a Zeiss (Cambridge, UK) LSM510 confocal
microscope.
Lifespan analysis. Groups of 15 newly eclosed males of each genotype were
placed into separate vials with food and maintained at 25 °C. The flies were
transferred into vials containing fresh food every 2 to 3 days, and the number of
dead flies was recorded. The data are presented as Kaplan–Meier survival
distributions, and the significance was determined by log-rank tests.
Climbing assay. The climbing assays were performed as previously
described21 using a countercurrent apparatus. A total of 15 to 20 male flies were
placed into the first chamber, tapped to the bottom and then given 20 s to climb a
distance of 10 cm. Those flies that successfully climbed 10 cm or beyond in 20 s
were then shifted to a new chamber, and both sets of flies were given another
opportunity to climb the 10 cm distance. This procedure was repeated a total of five
times. After five trials, the number of flies in each chamber was counted. A video
demonstrating the technique can be found at https://youtu.be/vmR6s_WAXgc. The
climbing index was measured by using a weighted average approach using the
following formula:
0  n0ð Þ þ 1  n1ð Þ þ 2  n2ð Þ þ 3  n3ð Þ þ 4  n4ð Þ þ 5  n5ð Þ
5  SUM n0:n5ð Þ
In this formula, n0 corresponds to the flies that fail the first trial and n1
to n5 the number of flies that successfully pass each respective trial.
At least 100 flies were used for each genotype tested.
Drosophila phenotypic analysis. To quantify the eclosion defects, adult
parent flies were removed 3 to 4 days after the setup of crosses. Eclosion of
progeny was monitored for 10 days after the first fly had hatched. The total
numbers of empty and full pupae cases were counted and used for statistical
analysis.
To quantify lethality, the number of both male and female park25 homozygotes to
total flies (park25homozygotes+heterozygotes) and the number of pink1B9 to total
males (pink1B9+FM6) were counted and used for statistical analysis.
To assess downturned wing phenotype, groups of ten 3-day-old male flies were
acclimatized for at least 1 h in fresh vials. The number of flies that presented with
downturned wings was counted. Counts were repeated three times to confirm the
result. The total number of flies with or without downturned wings were counted and
used for statistical analysis.
Microscopy-based assessment of mitochondrial function and
morphology. Measurements of Δψm in fly brains were performed as
previously described.5 Briefly, fly brains were loaded for 40 min at room temperature
with 40 nM TMRM in loading buffer (10 mM HEPES pH 7.35, 156 mM NaCl, 3 mM
KCl, 2 mM MgSO4, 1.25 mM KH2PO4, 2 mM CaCl2, 10 mM glucose) and the dye
was present during the experiment. In these experiments, TMRM is used in the
redistribution mode to assess Δψm, and therefore a reduction in TMRM
fluorescence represents mitochondrial depolarization. Confocal images were
obtained using a Zeiss 510 confocal microscope equipped with a 40 × oil
immersion objective. Illumination intensity was kept to a minimum (at 0.1–0.2% of
laser output) to avoid phototoxicity and the pinhole was set to give an optical slice of
2 μm. Fluorescence was quantified by exciting TMRM using the 565 nm laser and
measured above 580 nm. Z-stacks of 5 fields of 300 μm2 each per brain were
acquired, and the mean maximal fluorescence intensity was measured for each
group. Mitochondrial length was calculated as previously described22 by using the
‘ruler’ and ‘measurement’ tools in Photoshop CS3 Extended (San Jose, CA, USA)
to measure the length of mitoGFP-positive mitochondria across their largest
dimension.
Electron microscopy. For transmission electron microscopy (TEM), adult fly
thoraces were fixed overnight in 0.1 M sodium cacodylate buffer (pH 7.4) containing
2% paraformaldehyde, 2.5% glutaraldehyde and 0.1% Tween-20. Samples were post-
fixed for 1 h at room temperature in a solution containing 1% osmium tetroxide and
1% potassium ferrocyanide. After fixation, samples were stained en bloc with 5%
aqueous uranyl acetate overnight at room temperature; the samples were then
dehydrated via a series of ethanol washes and embedded in TAAB epoxy resin (TAAB
Laboratories Equipment Ltd, Aldermaston, UK). Semi-thin sections were stained with
toluidine blue, and areas of the sections were selected for ultramicrotomy. Ultrathin
sections were stained with lead citrate and imaged using a MegaView 3 digital camera
and iTEM software (Olympus Soft Imaging Solutions GmbH, Münster, Germany) in a
Jeol 100-CXII electron microscope (Jeol UK Ltd, Welwyn Garden City, UK).
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Analysis of dopaminergic neurons. Fly brains were dissected from
20-day-old flies and stained for anti-tyrosine hydroxylase (Immunostar) as previously
described.23 Brains were positioned in PBS+0.1% Triton in a coverslip clamp
chamber (ALA Scientific Instruments Inc., Farmingdale, NY, USA) using a harp
made of platinum wire and nylon string and imaged by confocal microscopy.
Tyrosine hydroxylase-positive PPL1 cluster neurons were counted per brain
hemisphere. Data acquired for the assessment of each genotype were obtained as
a single experimental set before statistical analysis.
Statistical analyses. Descriptive and inferential statistical analyses were
performed using GraphPad Prism 6 (www.graphpad.com). Computation of the
minimal sample size for the variables measured in this study was assessed by power
analysis, setting alpha initially to 0.05, using StatMate 2 (www.graphpad.com).
Data are presented as the mean values, and the error bars indicate±S.D. The
number of biological replicates per experimental variable (n) is indicated in either the
figures or figure legends. Parametric tests were used (performed using data obtained
from pilot experiments) after confirming that the variables under analysis displayed
Gaussian distributions using the D’Agostino-Pearson test (computed using GraphPad
Prism 5). The significance is indicated as *Po0.05, **Po0.01, ***Po0.001 and
****Po0.0001. For the statistical analysis of metabolites in flies, pair-wise
comparisons were performed using Welch’s t-tests. The q-value provides an
estimate of the false discovery rate (FDR) according to Storey and Tibshirani.24 The
investigators gathering quantitative data on biological samples were not blinded to the
sample identities at the time of analysis. No specific randomization strategies were
employed when assigning biological replicates to treatment groups.
Digital image processing. Fluorescence, transmission electron microscope
and western blot images were acquired as uncompressed bitmapped digital data
(TIFF format) and processed using Adobe Photoshop, employing established
scientific imaging workflows.25
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